Aging and the adrenal cortex

Experimental Gerontology

Volumn 33, Issue 7-8, 1998, Pages 897-910

  Yen, Samuel S C ^a   Laughlin, Gail A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal; Aging; Cortisol; DHEAS; IGF I

Indexed keywords

PEROXISOME PROLIFERATOR;

ADRENAL CORTEX; AGING; ANDROGEN SYNTHESIS; CELL LOSS; CONFERENCE PAPER; DRUG RECEPTOR BINDING; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIFESPAN; NERVE CELL; PRIORITY JOURNAL; STRESS;

EID: 0032442416     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(98)00046-1     Document Type: Conference Paper

References (74)

1. Albert D.H., Ponticorvo L., Lieberman S. Identification of fatty acid esters of pregnenolone and allopregnanolone from bovine corpora lutea. J Biol Chem. 255:1980;10618-10623.
2. Baulieu E.E. Three sulfate esters of 17-ketosteroids in the plasma of human subjects and after the administration of ACTH. J Clin Endocrinol. 20:1960;900-904.
3. Baulieu E.E. Neurosteroids Of the nervous system, by the nervous system, for the nervous system . Recent Prog Horm Res. 52:1997;1-32.
4. Belanger A., Candas B., Dupont A., Cusan L., Diamond P., Gomez J.L., Labrie F. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab. 79:1994;1086-1090.
5. Bird C.E., Murphy J., Boroomand K., Finnis W., Dressel D., Clark A.F. Dehydroepiandrosterone kinetics of metabolism in normal men and women . J Clin Endocrinol Metab. 47:1978;818-822.
6. Butemandt A., Dannenbaum H. Isoleierung eines neuen, physiologisch unwirksamen Sterinderivates aus Mannerharn, seine Verknupfung mit Dehydro-androsteron und Androsteron. Z Physiol Chem. 229:1934;192-195.
7. Carlstr, m K., Brody S., Lunell N.O., Lagrelius A., M, llerstrm G., Pousette A., Rannevik G., Stege R., Von Schoultz B. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum differences related to age and sex . Maturitas. 10:1988;297-306.
8. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocr Rev. 14:1993;20-39.
9. De Leon M.J., Mcrae T., Rusinek H., Convit A., De Santi S., Tarshish C., Golomb J., Volkow N., Daisley K., Orentreich N., McEwen B. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J Clin Endocrinol Metab. 82:1997;3251-3259.
10. Depergola G., Cospite M.R., Giagulli V.A., Giorgino F., Garruti G., Cignarelli M., Giorgino R. Insulin-like growth factor-1 (IGF-1) and dehydroepiandrosterone sulphate in obese women. Int J Obes Relat Metab Disord. 17:1993;481-483.
11. Deuschle M., Gotthardt U., Schweiger U., Weber B., K, orner A., Schmider J., Standhardt H., Lammers C.H., Heuser I. With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens. Life Sci. 61:1997;2239-2246.
12. Diamond P., Cusan L., Gomez J.L., B, langer A., Labrie F. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol. 150:1996;S43-S50.
13. Endoh A., Kristiansen S.B., Casson P.R., Buster J.E., Hornsby P.J. The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab. 81:1996;3558-3565.
14. Friess E., Trachsel L., Guldner J., Schier T., Steiger A., Holsboer F. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range. Am J Physiol. 268:1995;E107.
15. Givalois L., Li S., Pelletier G. Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in male and female rats. Mol Brain Res. 48:1997;107-114.
16. Guazzo E.P., Kirkpatrick P.J., Goodyer I.M., Shiers H.M., Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man relation to blood levels and the effects of age . J Clin Endocrinol Metab. 81:1996;3951-3960.
17. Guralnik J.M., Ferrucci L., Simonsick E.M., Salive M.E., Wallace R.B. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 332:1995;556-561.
18. Hesse V., Jahreis G., Schambach H., Vogel H., Vilser C., Seewald H.J., B, orner A., Deichl A. Insulin-like growth factor I correlations to changes of the hormonal status in puberty and age. Exp Clin Endocrinol. 102:1994;289-298.
19. Holloway L., Butterfield G.E., Hintz R.L., Gesundheit N., Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition and bone turnover in healthy elderly women. J Clin Endocrinol Metab. 79:1994;470-479.
20. Huizenga N.A., Koper J.W., De Lange P., Pols H.A., Stolk R.P., Grobbee D.E., De Jong F.H., Lamberts S.W. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab. 83:1998;47-54.
21. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
22. Jacobson L., Sapolsky R.M. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 12:1991;118-134.
23. Kern W., Dodt C., Born J., Fehm H.L. Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. J Gerontol A Biol Sci Med Sci. 51:1996;M3-M9.
24. Kirschbaum C., Schommer N., Federenko I., Gaab J., Neumann O., Oellers M., Rohleder N., Untiedt A., Hanker J., Pirke K.M., Hellhammer D.H. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men. J Clin Endocrinol Metab. 81:1996;3639-3643.
25. Kristiansen S.B., Endoh A., Casson P.R., Buster J.E., Hornsby P.J. Induction of steroidogenic enzyme genes by insulin and IGF-I in cultured adult human adrenocortical cells. Steroids. 62:1997;258-265.
26. Kudielka B.M., Hellhammer J., Hellhammer D.H., Wolf O.T., Pirke K.M., Varadi E., Pilz J., Kirschbaum C. Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impacts of a 2-week dehydroepiandrosterone treatment. J Clin Endocrinol Metab. 83:1998;1756-1761.
27. L'Allemand D., Penhoat A., Lebrethon M.C., Ard, vol R., Baehr V., Oelkers W., Saez J.M. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells. J Clin Endocrinol Metab. 81:1996;3892-3897.
28. Labrie F. Intracrinology. Mol Cell Endocrinol. 78:1991;C113-C118.
29. Labrie, F., , Diamond, P., Cusan, L., Gomez, J.L., Blanger, A., and Candas, B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82, 3498-3505, 1997.
30. Legrain S., Berr C., Frenoy N., Gourlet V., Debuire B., Baulieu E.E. Dehydroepiandrosterone sulfate in a long-term care aged population. Gerontology. 41:1995;343-351.
31. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 270:1995;12593-12956.
32. Magri F., Locatelli M., Balza G., Molla G., Cuzzoni G., Fioravanti M., Solerte S.B., Ferrari E. Changes in endocrine circadian rhythms as markers of physiological and pathological brain aging. Chronobiol Int. 14:1997;385-396.
33. Majewska M.D. Neurosteroids endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance . Prog Neurobiol. 38:1992;379-395.
34. Majewska M.D. Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect. Ann NY Acad Sci. 774:1995;111-120.
35. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 12:1991;141-147.
36. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr Opin Neurobiol. 5:1995;205-216.
37. Meaney M.J., Diorio J., Francis D., Widdowson J., Laplante P., Caldji C., Sharma S., Seckl J.R., Plotsky P.M. Early environmental regulation of forebrain glucocorticoid receptor gene expression implications for adrenocortical responses to stress . Dev Neurosci. 18:1996;49-72.
38. Meikle A.W., Stringham J.D., Woodward M.G., Bishop D.T. Heritability of variation of plasma cortisol levels. Metabolism. 37:1988;514-517.
39. Migeon C.J., Plager J.E. Identification and isolation of dehydroisoandrosterone from peripheral human blood. J Biol Chem. 209:1954;767-772.
40. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S.C. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
41. Morales, A.J. and Yen, S.S.C. ,The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin Endocrinol 1998 (in press).
42. Mortola J.F., Yen S.S.C. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 71:1990;696-704.
43. Munson P.L., Gallagher T.F., Koch F.C. , Isolation of dehydroisoandrosterone sulfate from normal male urine. J Biol Chem. 152:1944;67-77.
44. Nestler J.E., Barlascini C.O., Clore J.N., Blackard W.G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J Clin Endocrinol Metab. 66:1988;57-61.
45. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1984;551-555.
46. Orentreich N., Brind J.L., Vogelman J.H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab. 75:1992;1002-1004.
47. Paolisso G., Ammendola S., Del Buono A., Gambardella A., Riondino M., Tagliamonte M.R., Rizzo M.R., Carella C., Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function . J Clin Endocrinol Metab. 82:1997;2204-2209.
48. Pare W. The effect of chronic environmental stress on premature aging in the rat. J Gerontol. 20:1965;78-84.
49. Parker, C.R., JR., Faye-Petersen, O., Mason, J.L., and Grizzle, W.E. , Ontogeny and topology of 3β-hydroxysteroid dehydrogenase (HSD) and dehydroepiandrosterone sulfotransferase (DST) in the fetal and adult human adrenal. Proceedings of the annual meeting of the Society for Gynecologic Investigation (Abstract P257). 1995.
50. Parker C.R. Jr, Mixon R.L., Brissie R.M., Grizzle W.E. Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab. 82:1997;3898-3901.
51. Peters, J.M., , Zhou, Y.-C., Ram, P.A., Lee, S.S., Gonzalez, F.J., and Waxman, D.J. Peroxisome proliferator-activated receptor α required for gene induction by dehydroepiandrosterone-3β-sulfate. Mol Pharm 50, 67-74, 1996.
52. Pham-Huu-Trung M.T., Villette J.M., Bogyo A., Duclos J.M., Fiet J., Binoux M. Effects of insulin-like growth factor I (IGF-I) on enzymatic activity in human adrenocortical cells. Interactions with ACTH. J Steroid Biochem Mol Biol. 39:1991;903-909.
53. Ravaglia G., Forti P., Maioli F., Boschi F., Bernardi M., Pratelli L., Pizzoferrato A., Gasbarrini G. The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 81:1996;1173-1178.
54. Robel P., Baulieu E.E. Dehydroepiandrosterone (DHEA) is a neuroactive neurosteroid. Ann N Y Acad Sci. 774:1995;82-110.
55. Robel P., Baulieu E.E. Neurosteroids biosynthesis and function . Crit Rev Neurobiol. 9:1995;383-394.
56. Rotter J.I., Wong F.L., Lifrak E.T., Parker L.N. A genetic component to the variation of dehydroepiandrosterone sulfate. Metabolism. 34:1985;731-736.
57. Rudman D., Feller A.G., Nagraj H.S., Gergans G.A., Lalitha P.Y., Goldberg A.F., Schlenker R.A., Cohn L., Rudman I.W., Mattson D.E. Effects of human growth hormone in men over 60 years old. N Engl J Med. 323:1990;1-6.
58. Sapolsky R.M. Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav Brain Res. 57:1993;175-182.
59. Sapolsky R.M., Krey L.C., McEwen B.S. The adrenocortical stress-response in the aged male rat impairment of recovery from stress . Exp Gerontol. 18:1983;55-64.
60. Sapolsky R.M., Uno H., Rebert C.S., Finch C.E. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 10:1990;2897-2902.
61. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA. 93:1996;3908-3913.
62. Sladek C.D., Armstrong W.E. Gamma-aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurophyseal explants. Endocrinology. 120:1987;1576-1580.
63. Starkman M.N., Gebarski S.S., Berent S., Schteingart D.E. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 32:1992;756-765.
64. Thomas G., Frenoy N., Legrain S., Sebag-Lanoe R., Baulieu E.E., Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker. J Clin Endocrinol Metab. 79:1994;1273-1276.
65. Thompson J.L., Butterfield G.E., Marcus R., Hintz R.L., Van Loan M., Ghiron L., Hoffman A.R. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women. J Clin Endocrinol Metab. 80:1995;1845-1852.
66. Usiskin K.S., Butterworth S., Clore J.N., Arad Y., Ginsberg H.N., Blackard W.G., Nestler J.E. Lack of effect of dehydroepiandrosterone in obese men. Int J Obes. 14:1990;457-463.
67. Vamvakopoulos N.C., Chrousos G.P. Evidence of direct estrogenic regulation of human corticotropin releasing hormone gene expression potential implications for the sexual dimorphism of the stress response and immune/inflammatory reaction . J Clin Invest. 92:1993;1896-1902.
68. Van Cauter E., Leproult R., Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 81:1996;2468-2473.
69. Van Coevorden, A., Mockel, J., Laurent, E., Kerkhofs, M., L'Hermite-Balriaux, M., Decoster, C., , Nve, P., and Van Cauter, E. Neuroendocrine rhythms and sleep in aging men. Am J Physiol 26, E651-E656, 1991.
70. Vandervoort A.A., Kramer J.F., Wharram E.R. Eccentric knee strength of elderly females. Journal of Gerontology. 45:1990;B125-B128.
71. Wahli W., Braissant O., Desvergne B. Peroxisome proliferator activated receptors transcriptional regulators of adipogenesis, lipid metabolism and more . Chem Biol. 2:1995;261-266.
72. Welle S., Jozefowicz R., Statt M. Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans. J Clin Endocrinol Metab. 71:1990;1259-1264.
73. Wilkinson C.W., Peskind E.R., Raskind M.A. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging. Neuroendocrinology. 65:1997;79-90.
74. Wolf O.T., K, oster B., Kirschbaum C., Pietrowsky R., Kern W., Hellhammer D.H., Born J., Fehm H.L. A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels. Biol Psychiatry. 42:1997;845-848.